Neoplasms of the Ear and Temporal Bone


Classification of Neoplasms of the Ear And Temporal Bone

Box 24-1
Classification of Neoplasms of the Ear and Temporal Bone

External Ear

Benign

  • Epithelial/neuroectodermal/mesenchymal

    • Keratoacanthoma

    • Ceruminal gland neoplasms

    • Seborrheic keratoses

    • Squamous papilloma

    • Melanocytic nevi

    • Dermal adnexal neoplasms

    • Pilomatrixoma (calcifying epithelioma of Malherbe)

    • Neurilemmoma/neurofibroma

    • Osteoma; chondroma

    • Hemangioma

    • Others

Malignant

  • Epithelial/neuroectodermal/mesenchymal

    • Basal cell carcinoma

    • Squamous cell carcinoma and variants

    • (Verrucous carcinoma, spindle cell squamous carcinoma, adenoid squamous cell carcinoma, others)

    • Ceruminal gland adenocarcinomas

    • Malignant melanoma

    • Merkel cell carcinoma

    • Atypical fibroxanthoma

  • Others

Middle and Inner Ear

Benign

  • Epithelial

    • Middle ear adenoma

    • Middle ear papilloma

    • Others

  • Neuroectodermal/mesenchymal

    • Jugulotympanic paraganglioma

    • Meningioma

    • Acoustic neuroma

    • Others

Malignant

  • Epithelial

    • Middle ear adenocarcinoma

    • Primary squamous cell carcinoma

  • Neuroectodermal/mesenchymal

    • Endolymphatic sac papillary tumor

    • Rhabdomyosarcoma

    • Vascular (angiosarcoma; Kaposi sarcoma)

    • Lymphoproliferative (malignant lymphoma; plasmacytoma)

  • Secondary tumors

Benign Neoplasms of the External Ear

Keratoacanthoma (KA) ( Fig. 24-1 )

Definition: Solitary squamous epithelial neoplasm believed to arise from hair follicles, frequently occurring on sun-exposed areas of the skin and characterized by rapid development followed by involution and spontaneous regression.

Fig. 24-1, Keratacanthoma.

NOTE: Some experts believe that solitary keratoacanthomas represent squamous cell carcinoma with a real but limited ability to metastasize.

Clinical

  • No gender predilection; most frequently seen in the sixth to seventh decades of life

  • Frequently develop on sun-exposed skin:

    • Majority occur on the face (most commonly on the cheek and nose)

      • Approximately 10% occur on the external ear (pinna); occasionally may occur on the lips

  • Usually a solitary lesion but multiple KAs occur

  • Initially the lesion appears as an erythematous papule or may resemble a wart but over a 1- to 2-month period undergoes rapid enlargement to appear as an exophytic or dome-shaped nodule with a central keratin crater measuring from 1 to 3 cm in diameter.

  • Typically arise rapidly (6 to 8 weeks) followed by a stationary period lasting up to several months which in turn is followed by involution with spontaneous regression ultimately leading to (crateriform) scar.

  • Whole growth process may be seen over periods of several months up to a year.

  • Etiology is unknown but is probably the result of actinic damage.

  • Multiple and syndromic keratoacanthomas exist and may occur in patients with genetic predispo­sition.

  • Less common variants include:

    • Giant keratoacanthoma:

      • Grows rapidly and reaches a size of 5 cm or more

      • May cause destruction of underlying tissues

      • Spontaneous involution occurs after several months.

      • Most common sites are the nose and eyelids.

    • Keratoacanthoma centrifugum marginatum:

      • May reach 20 cm in diameter

      • No tendency to spontaneous involution

      • Peripheral extension with raised, rolled border and central atrophy

      • Most common sites are dorsa of hands and legs

    • Subungual keratoacanthoma:

      • Aggressive behavior that fails to regress spontaneously

      • Destructive growth in distal portion under a fingernail

  • Described as part of Muir-Torre syndrome, which is characterized by:

    • Multiple neoplasms of the skin, including those with sebaceous differentiation and internal (visceral) neoplasms, the most common of which are of colonic origin (adenocarcinoma, adenoma)

    • In Muir-Torre syndrome, KAs may be one of mul­tiple cutaneous lesions or represent the only type of cutaneous tumor present in this syndrome.

Pathology

Gross

  • Early lesions appear as an erythematous papule or a wart-like growth.

  • Mature lesions are elevated and firm with an exophytic or dome-shaped appearance characterized by skin-colored edges and a central cavity or crater filled with keratin debris.

  • Measures from 1 to 3 cm and occasionally may reach sizes measuring up to 5 cm

Histology

  • Cup-shaped symmetric lesion with deep bulbous lobules of squamous cells

  • Early lesion shows hyperkeratosis, parakeratosis, acanthosis with hypergranulosis, and papillomatosis with strands of atypical and dyskeratotic keratinocytes forming a central crater extending into the epidermis.

  • Mature lesions form a crater filled with hyper- and orthokeratotic material, below which is the epithelial proliferation composed of nests of large keratinocytes with a “glassy”-appearing or eosinophilic cytoplasm and prominent intercellular bridges.

  • Dyskeratosis and squamous pearl formation are commonly seen.

  • Transition area between the adjacent squamous epithelium and the hyperplastic epithelium forming the crater is noted by the formation of “shoulders,” a characteristic low-power finding.

  • A variable chronic inflammatory infiltrate may be seen in the dermis surrounding the lesion composed of mature lymphocytes, histiocytes, eosinophils, and polymorphonuclear leukocytes; neutrophilic intraepithelial “microabscesses” are often seen.

  • Vascular and perineural invasion may be seen.

  • With time the lesion involutes and is characterized by regression of the epithelial proliferation, a shallower central crater, granulation tissue proliferation, and fibrosis of the dermis.

Differential Diagnosis

  • Benign keratosis

  • Seborrheic keratosis, including inverted follicular keratoma

  • Squamous cell carcinoma:

    • Differentiation from squamous cell carcinoma is made on the basis of the overall architecture because cytologic atypia is not a reliable criterion for differentiating KA from squamous cell carcinoma.

    • Differentiation can be extremely difficult especially if less than adequate biopsy material is provided (e.g., from the central aspects of the tumor).

    • No reliable immunohistochemical staining and/or molecular biologic analyses allowing for differentiating KA from squamous cell carcinoma

Treatment and Prognosis

  • Complete surgical excision is the preferred treatment and is curative.

  • Despite the result of involution and regression, keratoacanthomas should be treated surgically for the following reasons:

    • Cosmetic considerations

    • Allow for the best overall architectural evaluation to confirm the diagnosis and help differentiate from a squamous cell carcinoma

    • Treatment would be the same for a well-differentiated squamous cell carcinoma in this location.

    • A small percentage of cases may recur.

  • Keratoacanthomas have been reported to metastasize; however, the metastases have been squamous cell carcinomas, suggesting that the primary tumors may have also been squamous cell carcinomas.

  • Presence of vascular and/or perineural invasion are not findings indicative of malignancy.

  • Diagnosis of KA as opposed to squamous cell carcinoma can be made if certain conditions are met, including:

    • Clear-cut clinical description of the lesion is provided.

    • Clinical history of rapid evolving lesion with KA as the primary clinical diagnosis

    • No history of immunosuppression

    • Adequate biopsy provided allowing for complete visualization of the lesion

    • Classic histologic findings are identified.

    • In the absence of these conditions a diagnosis of squamous cell carcinoma is likely.

Benign Ceruminal Gland Neoplasms

Definition: Benign tumor of cerumen-secreting modified apocrine glands (ceruminal glands) located in the external auditory canal.

General Comments

  • Ceruminal gland tumors arise from the cerumen-secreting modified apocrine glands (ceruminal glands) in the external auditory canal:

    • Ceruminal glands are located in the dermis of the cartilaginous (inner) portion (outer third) of the external auditory canal.

  • In general, ceruminal gland neoplasms are uncommon but represent one of the more common tumors of the external auditory canal.

  • The generic designation of ceruminoma should be avoided; ceruminal gland neoplasms should be specifically diagnosed according to tumor type.

  • The classification of ceruminal gland neoplasms includes benign and malignant tumors ( Box 24-2 ):

    • Benign ceruminal gland tumors include:

      • Ceruminal gland adenoma

      • Pleomorphic adenoma

      • Syringocystadenoma papilliferum

    • Malignant ceruminal gland tumors include:

      • Ceruminal gland adenocarcinoma

      • Adenoid cystic carcinoma

      • Mucoepidermoid carcinoma

    Box 24-2
    Classification of Ceruminal Gland Neoplasms

    Benign Ceruminal Gland Tumors

    • Ceruminal gland adenoma (ceruminoma)

    • Pleomorphic adenoma

    • Syringocystadenoma papilliferum

    Malignant Ceruminal Gland Tumors

    • Ceruminal gland adenocarcinoma

    • Adenoid cystic carcinoma

    • Mucoepidermoid carcinoma

Ceruminal Gland Adenoma ( Figs. 24-2 through 24-4 )

Synonym: Ceruminoma

Fig. 24-2, Ceruminal gland adenoma.

Fig. 24-3, Ceruminal gland adenoma.

Fig. 24-4, Ceruminal gland adenoma.

Clinical

  • Affect men more often than women; over a wide age range but is most frequently seen in the fifth to sixth decades of life

  • Symptoms include a slow-growing external auditory canal mass or blockage, hearing difficulty, and infrequently, otic discharge.

Pathology

Gross

  • Skin-covered, circumscribed, polypoid, or rounded mass ranging in size from 1 to 4 cm in diameter

  • Ulceration is uncommon and may suggest a malignant neoplasm.

Histology

  • Unencapsulated but well-demarcated glandular proliferation

  • Glands vary in size and may have various combinations of growth patterns including solid, cystic, and papillary; a back-to-back glandular pattern is commonly seen.

  • Glands are composed of two cell layers:

    • Inner or luminal epithelial cell is cuboidal or columnar appearing with an eosinophilic cytoplasm and a decapitation-type secretion (apical “snouts”) characteristic for apocrine-derived cells.

    • Outer cellular layer is a spindle cell with a hyperchromatic nucleus and represents myoepithelial or basal cells.

  • Intracytoplasmic golden yellow-brown granular-appearing pigment can be seen in the inner lining (luminal) cells representing cerumen.

  • Cellular pleomorphism and mitoses can be seen but are not prominent.

  • Intervening stroma shows a variable admixture of fibromyxomatous tissue.

  • Histochemistry:

    • Diastase-resistant, PAS-positive, and/or mucicarmine-positive intracytoplasmic and/or intraluminal material may be seen.

  • Immunohistochemistry:

    • Luminal cells:

      • Strongly and diffusely immunoreactive with CK7; CD117 positive

    • Myoepithelial or basal cells:

      • CK5/6, S100 protein, and p63 positive

  • Ultrastructure:

    • Epithelial (apocrine cell) and myoepithelial cell differentiation including:

      • Epithelial cells show features of apocrine cells, including apocrine caps, microvilli, cell junctions, secretory granules, vacuoles, lipid droplets, and siderosomes.

      • Concentric membranous bodies of the endoplasmic reticulum, phagocytic activity of the tumor cells, intracytoplasmic lumina, ciliated cells, and also spiny collagen in the tumor stroma can be seen.

Differential Diagnosis

  • Pleomorphic adenoma of ceruminal or parotid gland origin

  • Middle ear adenoma:

    • May perforate the tympanic membrane and appear to present as an external auditory canal mass, creating potential difficulty in differentiation from a ceruminal gland adenoma

    • Histologic features of both tumor types should allow for relatively easy differentiation from one another.

  • Ceruminal gland adenocarcinoma

Treatment and Prognosis

  • Complete surgical excision is the preferred treatment and is curative.

  • Recurrence of the tumor can occur and relates to inadequate surgical excision.

Other Ceruminal Gland Benign Neoplasms

Pleomorphic Adenoma of Ceruminal Gland Origin ( Fig. 24-5 )

  • Uncommon tumor

  • Histology is similar to pleomorphic adenomas of salivary gland origin, including a variable admixture of epithelial and myoepithelial components set in a myxoid to chondromyxoid stroma.

Fig. 24-5, Ceruminal gland pleomorphic adenoma.

Syringocystadenoma Papilliferum of Ceruminal Gland Origin ( Figs. 24-6 and 24-7 )

  • Benign tumor of apocrine gland origin that usually occurs on the scalp and face area

  • May originate in the external auditory canal from ceruminal glands

  • Histology is similar to tumors of the more common cutaneous sites and to the salivary gland tumor termed sialadenoma papilliferum (see Section 6).

Fig. 24-6, Syringocystadenoma papilliferum.

Fig. 24-7, Syringocystadenoma papilliferum.

Benign Mesenchymal Tumors of the External Ear

Epithelioid Hemangioma (EH) ( Figs. 24-8 to 24-9 )

  • Epithelioid hemangioma (EH), also known as angiolymphoid hyperplasia with eosinophilia (ALHE), has been a controversial lesion with regard to its classification (reactive proliferation or neoplastic process) and its relationship to Kimura disease:

    • A reactive cause especially secondary to trauma has been proposed but a neoplastic origin is favored.

    • Considered to represent the benign end of the spectrum of vascular tumors characterized by epithelioid endothelial cells, many of which are rich in lymphocytes and eosinophils

    • Malignant end of the spectrum includes epithelioid hemangioendothelioma and epithelioid angiosarcoma.

    • Shares features with Kimura disease, but the clinical and histologic differences allow these entities to be separated and considered as distinct clinicopathologic entities ( Table 24-1 )

      TABLE 24-1
      Epithelioid Hemangioma (EH) versus Kimura Disease
      EH Kimura Disease
      Gender M = F or F > M M > F
      Peak incidence 3rd to 5th decades 2nd to 3rd decades
      Head and neck site Periauricular, forehead Postauricular, scalp
      Lymphadenopathy Absent to rare Common
      Peripheral eosinophilia <25% >50%
      Location More superficial situated in subcutaneous, dermis More deeply situated extending to the subcutaneous fat, fascia, and skeletal muscle
      Histology Nodular vascular proliferation lined by plump-appearing (epithelioid) endothelial cells with pleomorphic changes and hyperchromatic nuclei, and accompanied by a prominent inflammatory cell infiltrate with variable admixture of lymphocytes, histiocytes, plasma cells, and eosinophils Vascular component is sparse with minimal epithelioid endothelial changes; lymphoid proliferation predominates, but prominent eosinophilic cell infiltrate, including eosinophilic microabscesses can be seen; associated fibrosis is present

Fig. 24-8, Epithelioid hemangioma.

Fig. 24-9, Epithelioid hemangioma.

Clinical

  • No gender predilection; most frequently occurs in the third through fifth decades of life

  • Subcutaneous proliferation with a predilection for the external ear (auricle and external canal), as well as other head and neck sites, including the scalp and forehead ( Fig. 24-8 )

  • Symptoms include pruritus and bleeding following scratching; regional lymphadenopathy and peripheral eosinophilia are uncommon but may be present.

  • History of trauma elicited in a number of cases, as well as the microscopic impression of vascular damage, and the demonstration of immunoglobulin deposits in the vessels have led several observers to favor a reactive or reparative etiology.

  • Hormonal influences may play a role in some cases, as suggested by the association with pregnancy in some patients and by the age and gender distribution of the disease.

  • Human herpesvirus 8 (HHV-8) has not been identified in association with EH.

Pathologic Features

Gross

  • Characterized by single or multiple, pink to red-brown indurated cutaneous papules or subcutaneous nodules

  • Measure from a few millimeters to 1 cm in diameter

  • Clusters of papules may coalesce to form large plaque-like lesions.

Histology ( Fig. 24-9 )

  • Characterized by a nodular vascular proliferation accompanied by a variably dense lymphoid infiltrate rich in eosinophils

  • Process is circumscribed but not encapsulated and may involve the subcutis or dermis, or both.

  • Vascular component:

    • Varies in size from capillary to medium-sized arteries and veins

    • Vascular spaces are lined by plump-appearing (epithelioid) endothelial cells with pleomorphism, hyperchromatic nuclei, copious eosinophilic cytoplasm, and inconspicuous nucleoli.

    • Frequently, the endothelial cells protrude into the vessel lumen in a “hobnail” fashion, creating a cobblestone-like appearance.

    • Increased mitotic activity and moderate to marked nuclear pleomorphism not identified

  • Lobular arrangement of the proliferating vessels may be evident; however, the distribution of vessels is more haphazard in some lesions:

    • Vessels vary from irregular, poorly canalized thin-walled spaces to rounded well-formed vessels with thickened walls.

    • In some cases there is evidence of disruption or damage to some of the involved vessels.

    • Origin from a small artery or vein is common but may depend on adequate sampling.

    • Common for the entire lesion to be intravascular (intravascular EH):

      • Differ from “conventional” EH by virtue of pre­­­dominant spindle cell (pericytic) component

      • Predominantly occurs in young to middle-aged adults

      • Solitary nodule most often in head and neck or upper limb

  • Inflammatory component surrounds the vascular proliferation and is characterized by an admixture of lymphocytes, histiocytes, and eosinophils; on occasion, eosinophils may be few in number or absent.

  • Immunohistochemistry:

    • Endothelial cells are:

      • CD31, ERG, and to a lesser extent CD34 positive

      • Glucose transporter protein 1 (GLUT1) negative

      • Rarely cytokeratin positive

Differential Diagnosis

  • Lobular capillary hemangioma:

    • Prominence of epithelioid endothelial features and associated lymphoplasmacytic and eosinophilic infiltrate contrast with findings in hemangiomas.

  • Infantile hemangioma:

    • GLUT1 positive

  • Angiosarcoma:

    • Shows a diffusely infiltrative lesion composed of anastomosing vascular channels lined by pleomorphic cells with increased mitotic activity

    • Presence of the characteristic inflammatory infiltrate in EH typically not found in angiosarcoma

Treatment and Prognosis

  • Local surgical excision or desiccation are the preferred treatments and are curative:

    • Rarely, lesions may regress.

  • Recurrence reported in up to one-third of cases

  • Metastasis virtually never occurs.

  • Superficial radiotherapy results in at least partial response in the majority of patients.

  • Intralesional or systemic steroids, cryotherapy, and intralesional vincristine, bleomycin, and fluorouracil not proven to be curative

Kimura Disease ( Fig. 24-10 )

Clinical

  • Not considered synonymous with EH

  • Occurs in subcutis of the head and neck; other less common sites of involvement include groin, extremities, and chest wall

  • In contrast to EH:

    • Occurs primarily in Asians and tends to affect males

    • Often associated with regional lymphadenopathy and peripheral eosinophilia

    • Increased serum immunoglobulin E (IgE), proteinuria, and nephrotic syndrome may occur as part of the disease.

    • Tend to be larger lesions that are predominantly subcutaneous nodules with a tendency to occur in locations other than in the head and neck

  • Etiology is unknown:

    • Presence of peripheral eosinophilic and elevated serum IgE suggests immunologic reaction to an unknown stimulus.

Fig. 24-10, Kimura disease.

Pathology

Histology

  • Shares histologic features with EH but differences are seen, including:

    • Lymphoid proliferation, including germinal centers, predominates; the vascular component is sparse and exhibits minimal epithelioid endothelial changes.

    • Lesion is usually located much deeper than EH, often extending to the fascia and to skeletal muscle, and the subcutaneous fat is usually fibrotic.

    • Eosinophils are always numerous in Kimura disease but may be sparse or even absent in EH.

    • Eosinophilic epithelioid granulomatous reaction and/or eosinophilic microabscess formation may be identified.

Differential Diagnosis

  • Lobular capillary hemangioma

  • Angiosarcoma

Treatment and Prognosis

  • Local surgical excision or desiccation are the preferred treatments and are curative.

  • Recurrence occasionally occurs.

  • Malignant transformation or association with malignancy not reported

Other Benign Mesenchymal Neoplasms of the External Ear and Auditory Canal

  • Mesenchymal tumors of the external auditory canal are rare and include osteoma, chondroma, leiomyoma, schwannoma, and myxomas.

Osteoma

  • In contrast to exostosis, osteomas are true neoplasms of bone capable of unlimited growth.

  • Occurs in the external auditory canal presenting as an asymptomatic solitary mass

  • Histologically is composed of mature bone with associated intraosseous fibrovascular tissue

Treatment and Prognosis

  • Surgery is curative.

Myxomas of the External Ear and External Auditory Canal ( Fig. 24-11 )

  • Described in Carney complex as an autosomal-dominant syndrome complex that includes:

    • Cardiac myxomas:

      • May be associated with peripheral tumor emboli

      • Approximately one-quarter of all patients with cardiac myxomas die of its complications.

    • Cutaneous myxomas:

      • Tend to appear in early adulthood

      • Predilection for eyelids

      • Range from small sessile papules to large pedunculated, finger-like lesions

      • In most cases are multiple

      • Found in dermis or subcutis

      • Usually circumscribed

      • Significant percentage of patients may have myxoma of external ear:

        • 85% of patients with myxoma of external ear have Carney complex

    • Spotty pigmentation:

      • Lentigines on face and vermilion border of lips

      • Blue nevi including epithelioid blue nevi

    • Endocrine disease/tumors:

      • Primary pigmented nodular adrenocortical disease causing Cushing syndrome

      • Pituitary adenoma causing acromegaly

      • Sexual precocity associated with testicular lesions (e.g., Sertoli cell tumor)

      • Thyroid diseases (hyperplasia)

      • Increase risk of pancreatic ductal and acinar cell neoplasms

    • Psammomatous melanotic schwannoma

    • Occasionally associated with breast lesions including multifocal myxoid fibroadenomas and myomatosis

  • Most patients with Carney complex harbor mutation of PRKAR1A gene located at 17q22-24 encoding regulatory R1 alpha subunit of protein kinase A.

  • Histology characterized by the presence of sparse cytologically bland spindle- and stellate-shaped cells in abundant myxoid stroma and prominent capillary vasculature:

    • Lesion consists chiefly of mucoid material in which are suspended a loose framework of reticulin fibers.

    • Cellular component consists of a population of spindled to stellate cells with tiny pyknotic nuclei and delicate cytoplasmic process.

    • Cellular pleomorphism is not seen.

    • Periphery of the tumor is surrounded by a pseudocapsule of condensed reticulin fibers and compressed host tissue, particularly skeletal muscle.

    • Often associated with basaloid proliferation of overlying epithelium:

      • May result in misdiagnosis of basal cell carcinoma or trichofolliculoma

    • Myxoid matrix in myxoma stains with alcian blue and is hyaluronidase sensitive

    • Mucicarmine and colloidal iron stain the myxoid material.

    • Immunohistochemistry of cellular component includes:

      • CD34 and vimentin positive

      • Cells may stain for actins and/or desmin, suggesting myofibroblastic differentiation.

      • Typically negative for S100 protein, MUC4, cytokeratins

Fig. 24-11, External auditory canal myxoma.

Differential Diagnosis

  • Myxoid neoplasms:

    • Myxoid change occurs in a variety of benign neoplasms, including neurofibroma, neurilemmoma, and lipoma, may mimic myxoma, especially in limited biopsy material.

    • Of greater concern is that the histologic pattern in myxomas may mimic myxoid soft tissue malignancies, which are much more common in this location, particularly embryonal rhabdomyosarcoma, and less commonly undifferentiated pleomorphic sarcoma, low-grade fibromyxoid sarcoma, myxoid liposarcoma, and myxoid chondrosarcoma.

    • In contrast to myxoma, sarcomas display:

      • Much greater cellularity

      • A richer vascular pattern often with delicate plexiform capillary vascular network

      • Differing cytologic features including cellular pleomorphism with increased mitotic figures; multinucleated giant cells in undifferentiated pleomorphic sarcoma; cytoplasmic MUC4 in low-grade fibromyxoid sarcoma; lipoblasts in liposarcoma; rhabdomyoblasts in rhabdomyosarcoma; and atypical chondroblasts in chondrosarcoma are distinctive features for these sarcoma types.

Treatment and Prognosis

  • Surgery is the preferred treatment.

  • Although soft tissue myxomas lack a discrete capsule, they rarely recur after excision.

Benign Neoplasms of the Middle Ear and Temporal Bone

Middle Ear Adenoma (MEA) ( Figs. 24-12 through 24-14 )

Definition: Benign glandular neoplasm arising from the middle ear mucosa.

Fig. 24-12, Middle ear adenoma.

Fig. 24-13, Middle ear adenoma.

Fig. 24-14, Middle ear adenoma.

Clinical

  • Generally considered an uncommon neoplasm

  • No gender predilection; occurs over a wide age range but is most common in the third to fifth decades of life

  • Any portion of the middle ear may be affected, including the eustachian tube, mastoid air spaces, ossicles, and chorda tympani nerve.

  • Most common symptom is that of unilateral conductive hearing loss:

    • Fullness, tinnitus, and dizziness may also occur.

    • Pain, otic discharge, and facial nerve paralysis rarely occur and may be indicative of a malignant process.

  • Otoscopic examination in the majority of cases will identify an intact tympanic membrane with tumor confined to the middle ear space with possible extension to the mastoid; occasionally, the adenoma will perforate through the tympanic membrane with extension into and presentation as an external auditory canal mass.

  • No known etiologic factors related to the development of MEA:

    • Not associated with a prior history of chronic otitis media

    • Concurrent cholesteatomas may be seen but there is no known association between these two lesions.

  • Radiologic imaging:

      • In its more typical radiologic presentation, appears as a relatively avascular soft tissue density without evidence of destructive, invasive, or erosive properties.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here